eral types of central neurons, including striatal and hippo-B. A. MacVicar, and J. F. MacDonald. Neurotrophin modulation campal neurons. High-affinity neurotrophin receptors posof NMDA receptors in cultured murine and isolated rat neurons. J. sess intrinsic tyrosine kinase activity. Neurotrophin receptors Neurophysiol. 78: 2363Neurophysiol. 78: -2371Neurophysiol. 78: , 1997. Patch-clamp and calcium imwith high affinity for brain-derived neurotrophic factor aging techniques were used to assess the acute effects of the neuro-(BDNF), neurotrophin-4 (NT-4; TrkB) and neurotrophin-3 trophins, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3; TrkC) are distributed widely throughout the CNS (NT-3), and nerve growth factor (NGF), on the responses of cultured and have been localized to hippocampal and striatal neurons, and acutely isolated hippocampal and cultured striatal neurons to the whereas receptors for nerve growth factor (NGF; TrkA), glutamate receptor agonist N-methyl-D-aspartic acid (NMDA). The although present in cholinergic neurons of the striatum effects of BDNF on NMDA-activated currents were examined in greater detail. Currents evoked by NMDA, and the accompanying (Bothwell 1995; Holtzman et al. 1995; Lindsay et al. 1994), changes in intracellular calcium, were enhanced by low concentrations appear to be absent in hippocampal neurons and GABAergic of the neurotrophins (1-20 ng/ml). The potentiation by the neurostriatal neurons (Ip et al. 1993). The administration of neurotrophins was rapid in onset and offset (õ1 s). The neurotrophins also trophins can protect neurons against metabolic stress and reduced desensitization of these currents in most cells. The enhanceexcitotoxicity (Cheng and Mattson 1994). However, Koh ment of NMDA-activated currents by BDNF was observed using both et al. (1995) have reported recently that in cultured cortical perforated and whole cell patch recording techniques and could be neurons BDNF, NT-3, or NT-4 but not NGF exacerbated demonstrated in outside-out patches. Furthermore, its effects were not the toxicity associated with activation of the N-methyl-Dattenuated by pretreatment with the protein kinase inhibitors genistein aspartate (NMDA) subclass of glutamate receptors. Adminor 1-(5-isoquinolynesulfony)2-methylpiperazine (H7). Therefore, istration of NMDA also has been associated with an enthe actions of BDNF do not appear to be mediated by phosphorylation.
. Patch-clamp and calcium imwith high affinity for brain-derived neurotrophic factor aging techniques were used to assess the acute effects of the neuro-(BDNF), neurotrophin-4 (NT-4; TrkB) and neurotrophin-3 trophins, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3; TrkC) are distributed widely throughout the CNS , and nerve growth factor (NGF), on the responses of cultured and have been localized to hippocampal and striatal neurons, and acutely isolated hippocampal and cultured striatal neurons to the whereas receptors for nerve growth factor (NGF; TrkA), glutamate receptor agonist N-methyl-D-aspartic acid (NMDA). The although present in cholinergic neurons of the striatum effects of BDNF on NMDA-activated currents were examined in greater detail. Currents evoked by NMDA, and the accompanying (Bothwell 1995; Holtzman et al. 1995; Lindsay et al. 1994) , changes in intracellular calcium, were enhanced by low concentrations appear to be absent in hippocampal neurons and GABAergic of the neurotrophins (1-20 ng/ml). The potentiation by the neurostriatal neurons (Ip et al. 1993) . The administration of neurotrophins was rapid in onset and offset (õ1 s). The neurotrophins also trophins can protect neurons against metabolic stress and reduced desensitization of these currents in most cells. The enhanceexcitotoxicity (Cheng and Mattson 1994) . However, Koh ment of NMDA-activated currents by BDNF was observed using both et al. (1995) have reported recently that in cultured cortical perforated and whole cell patch recording techniques and could be neurons BDNF, NT-3, or NT-4 but not NGF exacerbated demonstrated in outside-out patches. Furthermore, its effects were not the toxicity associated with activation of the N-methyl-Dattenuated by pretreatment with the protein kinase inhibitors genistein aspartate (NMDA) subclass of glutamate receptors. Adminor 1-(5-isoquinolynesulfony)2-methylpiperazine (H7). Therefore, istration of NMDA also has been associated with an enthe actions of BDNF do not appear to be mediated by phosphorylation.
Similar enhancements were observed with NT-3 and NT-4 and with hanced expression of the neurotrophins themselves, likely NGF despite the fact that hippocampal neurons lack TrkA receptors. as a compensatory response to excitotoxicity (Hughes et al. All together this evidence suggests that the enhancement of NMDA-1993). evoked currents is unlikely to be mediated through the activation of The NMDA receptor also appears to play a trophic-like growth factor receptors. Modulation of NMDA responses by BDNF role in the development of synaptic connections in the CNS was dependent on the concentration of extracellular glycine. The most (Constatine-Paton 1990; Komuro and Rakic 1993) , and, in pronounced potentiation by BDNF was observed at low concentralow concentrations, NMDA can enhance the outgrowth and tions, whereas no potentiation was observed in saturating concentrabranching of neurons in culture (Brewer et al. 1993 ). The tions of glycine, suggesting that BDNF may have increased the affinity influx of calcium through this channel likely contributes both of the NMDA receptor for glycine. However, the competitive glycineto its excitotoxic as well as its trophic-like activities. Alsite antagonist 7-chloro-kynurenic acid blocked the enhancement by BDNF without shifting the dose-inhibition relationship for this antago-though it is unlikely that Trk receptor activation would lead nist, and Mg 2/ consistently depressed the potentiation of NMDAdirectly to phosphorylation of the NMDA receptor, it is posevoked currents by BDNF, indicating that BDNF does not alter glysible that subsequent activation of other protein kinases cine affinity. BDNF also reversibly increased the probability of openmight modulate the activity of this channel (Raymond et al. ing of NMDA channels recorded from outside-out patches taken from 1993). However, we report that neurotrophins can enhance cultured hippocampal neurons. Other unrelated peptides including rapidly and reversibly the activity of NMDA receptors by a dynorphin and somatostatin also caused a glycine-dependent enhancemechanism that involves neither Trk receptors nor activation ment of NMDA currents and depressed the currents in saturating of protein kinases. Instead, neurotrophins as well as other concentrations of glycine. In contrast, a shortened analogue dynorphin peptides, can act to directly modulate the activity of the (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , which lacks N-terminus glycine residues, and another peptide NMDA receptor. met-enkephalin were without effects on NMDA currents recorded in low concentrations of glycine. Our results suggest that neurotrophins and other peptides can serve as glycine-like ligands for the NMDA M E T H O D S receptor.
Cell culture and acute dissociation
Hippocampal and striatal tissue were obtained from mouse em-
bryos at E14 or E13, respectively. Cells were plated (1 1 10 06 cells per milliliter) and grown in the presence of serum (hippocampal Neurotrophins are small (Ç13 kDa) basic endogenous neurons) or in defined medium (striatal neurons) for 12-20 days as previously described (MacDonald et al. 1989; Weiss et al. proteins that increase the growth and differentiation in sev-1993). CA1 pyramidal neurons were acutely isolated from 2-wk-video rates using an image processing board (DT2867) in a PC-type computer controlled by Axon Imaging Workbench soft-old rats according to the technique described by Wang and Mac-Donald (1995) . Briefly, Wistar rats (2 wk old) were anesthetized ware (AIW, Axon Instruments). The shutter and filter wheel also were controlled by AIW to allow timed illumination of cells at 340 with ether and killed by decapitation using a guillotine. The brain then was removed rapidly and rinsed with cold extracellular solu-and 380 nm excitation wavelengths. Ratio images were analyzed by averaging pixel ratio values in circumscribed regions of all tion (see below). Each hippocampus was isolated surgically and then cut into 300-to 500-mm-thick slices by hand using a razor responding cells in the field of view. The values were exported from AIW to a spreadsheet program (Excel 5.0) and plotted in blade. The slices were treated for 20-30 min with a solution containing 0.3-0.5 mg/ml papain (EC 3.4.22.2-1.1 units/mg solids, GraphPad. derived from papaya latex, Sigma, P-3250), and neurons then were isolated mechanically from the CA1 region of the slice using two R E S U L T S fire-polished glass pipettes.
BDNF potentiates NMDA-evoked responses Electrophysiology
We initially employed the perforated patch technique to Recording electrodes with resistances of 3-5 MV were conexamine the effects of BDNF on NMDA-induced currents structed from thin-walled borosilicate glass (1.5 mm diameter, while minimally disturbing the cytosol of the cells (Fig. 1,   WPI ). Patch-clamp recordings were made in the perforated, whole cell, and outside-out patch configurations using an Axopatch 1-D amplifier (Axon Instruments, Foster City, CA). For perforated and whole cell recordings, data were digitized, filtered (2 kHz), and acquired on-line using the program pClamp 5.5.1 (Axon Instruments). For outside-out membrane patch recordings, single-channel events first were recorded on video tape using a digital data recorder (VR-10, Instrutech, Mineola, NY) and later played back and acquired using the pClamp 6 program (Axon Instruments). The single-channel open probability was determined from the ratio of the time spent in the open state to the duration of recording:
where t is the amount of time that n channels are open and the N is the maximum number of levels observed in the patch. Data were expressed as the means { SE, and the Student's t-test was used to examine the statistical significance of differences between groups.
The extracellular solutions contained (in mM) 140 NaCl, 1.3 or 2 CaCl 2 , 5.0 or 5.4 KCl, 10 or 25 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 33 or 10 glucose, and 0.0005-0.001 tetrodotoxin (TTX; pH 7.4 using NaOH; 320-335 mOsM). Perforated patch electrodes were filled with (in mM) 120 KCl, 5 MgCl 2 , 40 HEPES, and 10 ethylene glycol-bis(b-aminoethyl ether)-N,N,N,N-tetraacetic acid (EGTA) plus 0.45 mg/ml nystatin and a few crystals of pluronic acid. Whole cell patch electrodes contained (in mM) 140 CsF or 120 KCl, 35 CsOH, 10 or 40 HEPES, 2 or 5 MgCl 2 , 11 or 10 EGTA, 2 tetraethylammonium, 1 CaCl 2 , and 4 Na 2 ATP or 2 MgATP (pH 7.3 using CsOH or NaOH; 300 mosM). All experiments were performed at room temperature (20-22ЊC). Various concentrations of glycine (Sigma), NMDA (Sigma), MgCl 2 (Aldrich Chemical, Milwaukee, WI), BDNF, NGF, NT-3, NT-4 (Pepro Tech, Rocky Hill, NJ and Intergen, NY) and 7-chloro-kynurenic acid (Tocris, Bristol, UK) were added to give the concentrations indicated in the text and figure legends. In some experiments, we also applied somatostatin, met-enkephalin, dynorphin (1-17), and dynorphin (6-17) (Sigma and/or Penisula). A multibarrel perfusion system was employed to achieve a rapid exchange of solutions.
Calcium imaging
FIG . 1. Brain-derived neurotrophic factor (BDNF) potentiates N-Cultured striatal neurons were incubated in fura-2-acetoxymethyl-D-aspartate (NMDA)-activated currents and NMDA-induced increases in intracellular calcium levels. Perforated patch recordings demon-methyl ester (6 mM) dissolved in dimethyl sulfoxide with pluronic strated that BDNF enhanced NMDA-activated currents in cultured striatal acid in minimal essential media for 30-40 min at 37ЊC as described neurons (A). Holding potential, 070 mV. Inset: control response to NMDA previously (Weiss et al. 1993) . Coverslips with fura-2-loaded scaled to the peak of the response observed with BDNF. In whole cell cells were transferred to a perfusion chamber on an inverted microrecordings from isolated CA1 hippocampal pyramidal neurons, BDNF descope (Zeiss, Axiovert). Cells were illuminated using a xenon creased the desensitization of NMDA-evoked currents (B). Holding potenlamp (75 W) and were observed using a 125 plan-neofluar objectial, 060 mV. Fura-2, AM ratiometric imaging of intracellular calcium tive on an inverted microscope (Zeiss). Recordings were done at concentration in striatal neurons showed that BDNF increased the magniroom temperature. Video images were obtained using a CCD camtude of the NMDA-activated calcium influx (C). Shown are superimposed era (Cohu 4982) coupled to an image intensifier (Videoscope KS data traces from 10 cells. All experiments were performed in the absence of added glycine. 1381 Recordings were made from cultured hippocampal neurons using the whole cell patch-clamp technique. Applications of different concentrations of BDNF were superimposed on responses to NMDA (100 mM) recorded in the absence of added glycine and Mg 2/ (A). Dose-dependent enhancement by BDNF is plotted in C for a series of 6 cells. Maximal effect was not determined, and therefore the data were not further analyzed. In another neuron, an application of BDNF (10 ng/ml) was superimposed on an application of NMDA (100 mM) and then repeated at a series of different holding potentials (B). No apparent voltage-dependence to the enhancement by BDNF was observed and the plots (D) of NMDA (control) and NMDA / BDNF currents were near linear (n Å 8).
A). The extracellular solution did not contain added glycine stants of desensitization (cultured neurons t control Å 594 { 76 ms; t BDNF Å 908 { 125 ms, n Å 10, P õ 0.05; isolated or Mg 2/ . In previous experiments, we have estimated the concentration of contaminating glycine in our solutions to hippocampal neurons t control Å 290 { 25 ms; t BDNF Å 433 { 43 ms, n Å 9, P õ 0.01) with little or no change in the be Ç20 nM (Wang and MacDonald 1995) hence responses to NMDA can be observed readily in solutions containing amplitude of the peak current (e.g., Fig. 1B ). The effects of BDNF were observed consistently in cultured hippocampal no added glycine. In cultures, the cells release additional neurons grown in the presence of serum (53 out of 59), but glycine such that the concentrations of glycine can vary the response was observed less frequently in murine striatal substantially from dish to dish. In cultured hippocampal and cells grown in serum free medium (71 out of 102). We striatal neurons (no added glycine), BDNF (1-20 ng/ml) attribute the lack of responsiveness in some cases to the caused an enhancement of NMDA-evoked currents (Fig. variable concentrations of free glycine found in such cultures 1A). BDNF also enhanced the currents recorded from (also see below). The enhancement by BDNF was doseacutely isolated CA1 pyramidal neurons of the rat hippocamdependent (Fig. 2, A and C) and was similar at positive and pus (Fig. 1B) . The enhancement of NMDA-activated curnegative membrane potentials (Fig. 2B ). Plotting current rents was observed when the neurons were either preexposed versus holding potential (between 080 and /60 mV) demto the neurotrophin (Fig. 1A) or when the neurotrophin was onstrated that the effect of BDNF was voltage independent simply included with NMDA itself (Fig. 1B) . The enhance- (Fig. 2D ). The BNDF effect was rapid in onset and offset ment by BDNF was readily demonstrable using whole cell (Fig. 2, A and B) , and these parameters did not vary signifipatch recordings, and no ''run-down'' of the potentiation of cantly at different holding potentials (not shown). NMDA currents was observed during prolonged recordings lasting ú1 h (not shown). The enhancement of NMDA-We then used calcium imaging techniques to monitor intracellular calcium levels with the objective of examining the evoked currents by BDNF was manifested in two different ways. In most cultured cells, the peak and steady state cur-effect of BDNF on NMDA-evoked increases in intracellular calcium. In cultured striatal neurons, BDNF (10 ng/ml or rents were potentiated, and desensitization was reduced (e.g., Fig. 1A) , whereas in some cultured striatal cells and in all approximate equivalent of 1 nM) reversibly enhanced the Ca 2/ -response induced by applications of NMDA (Fig. 1C) . isolated neurons examined, the major action was a reduction of desensitization reflected as an increase in the time con-BDNF had no effect on the Ca 2/ -response elicited by the application of solutions containing high K / (50 mM; not shown). These data suggest that the potentiation of NMDAevoked responses by the neurotrophins is unlikely to be me-shown). These results are in agreement with our results from electrophysiological studies. diated by the activation of a specific Trk receptor because TrkA receptors that preferentially bind NGF are absent. The involvement of p75 receptors in the neurotrophin re-NT-3 and NGF also potentiate NMDA-evoked responses sponse is also unlikely due to the rapid onset of the response Noncholinergic neurons of the hippocampus and striatum (õ1 s). express TrkB and TrkC receptors that preferentially bind BDNF and NT-3. In contrast, TrkA receptors, which prefer-Effects of BDNF are not blocked by protein kinase entially bind NGF, are absent (Ip et al. 1993) . To test if the inhibitors enhancement by BDNF was mediated through the selective activation of a Trk receptor, we examined the actions of the Neurons were treated with the tyrosine kinase inhibitor genistein to test whether or not tyrosine phosphorylation was different neurotrophins (Fig. 3) . Each of the neurotrophins (BDNF, NGF, and NT-3) enhanced NMDA-activated cur-involved in the response to BDNF. Pretreatment of cultured hippocampal neurons with genistein, which should have rents (Fig. 3, A and C) and increased calcium responses to NMDA (Fig. 3, B and D) . There were no significant differ-blocked the intrinsic tyrosine kinase activity of the growth factor receptors (50 mM, n Å 5), failed to alter the enhance-ences in the magnitude of the effect of BDNF, NGF, and NT-3. In preliminary experiments, NT-4 also enhanced ment of NMDA-evoked currents (not shown). Furthermore, applications of the relatively nonspecific kinase inhibitor NMDA-evoked currents and calcium responses (data not FIG . 3. Other members of the neurotrophin family also enhance NMDA-activated currents and calcium signals. Whole cell recordings revealed that BDNF, nerve growth factor (NGF), and neurotrophin-3 (NT-3) each potentiated NMDA-activated currents in a cultured striatal neuron (A). Holding potential, 070 mV. Ratiometric calcium imaging techniques demonstrated that NGF, BDNF, and NT-3 also increased the magnitude of NMDA-evoked calcium influx in cultured striatal neurons (B). Neurotrophins (BDNF, NGF, and NT-3) enhanced NMDA-mediated currents in the absence of added glycine. Summary data from 15 or 16 cells is shown (C). Normalized calcium imaging data from 28 cells also is shown (no added glycine) ( D).
1-(5-isoquinolynesulfony)2-methylpiperazine (H7; 50 mM, n Å 4) were ineffective in modulating the effects of BDNF. These results suggest that the enhancement of NMDA-activated currents by BDNF was not mediated by protein kinase activation.
Enhancement of NMDA-evoked currents by BDNF is glycine dependent
We then examined the effects of changing the extracellular concentration of glycine on the response to BDNF. The actions of BDNF were found to be strongly dependent on the concentration of added glycine (Fig. 4) . The greatest potentiation was observed in the absence of added glycine (Fig. 4A) , whereas a small depression of NMDA-evoked responses was observed in saturating concentrations of this coagonist (Fig. 4B ; n Å 5, mean Å 5.7 { 2.0%). This differs from the effect of polyamines and divalent cations, which enhance NMDA currents in the presence of saturating concentrations of glycine (Benveniste and Mayer 1993; Paoletti et al. 1995) .
The dependence of the effects of BDNF on the concentration of glycine together with its ability to reduce desensitization suggests that neurotrophins may enhance the affinity of the NMDA receptor for glycine. such an increase in the affinity for glycine is to examine 060 mV. Increasing concentrations (1-50 mM) of the competitive glycinewhether or not a substance can influence the effectiveness site antagonist 7-chloro-kynurenic acid progressively depressed NMDAof competitive antagonists of the glycine site. For example, evoked currents (reduced the peak and increased desensitization; B). These experiments were carried out in the presence of a saturating concentration spermine (Benveniste and Mayer 1993) and Mg 2/ (Wang (10 mM) of glycine. If BDNF were to increase the affinity of glycine for and MacDonald 1995) can shift appropriately the dose-inhiits binding site, it would have been anticipated that it also would reduce bition curves for 5,7-dichloro-kynurenic and 7-chloro-kynthe effectiveness of 7-chloro-kynurenic acid. However, in all of the neurons urenic acids, respectively. However, we were unable to retested BDNF had no effect on NMDA-evoked currents at any of the antagonist concentrations tested (n Å 6). produce any such shift in the presence of 7-chloro-kynurenic acid as the response to BDNF was blocked completely (Fig.  5 ) at all concentrations of the antagonist tested (1-50 mM).
We also examined the effect of BDNF on the glycine concentration-response relationship in isolated neurons avoiding the higher level of glycine concentrations associated with neurons in cultures (Wang and MacDonald 1995) . However, we could not detect a change in the apparent affinity of the receptor for glycine (control EC 50 Å 496 { 99 nM; BDNF EC 50 Å 481 { 134, n Å 5, P ú 0.05). These results suggests that BDNF does not increase the affinity of the receptor for glycine.
Mg 2/ depresses the BDNF-induced enhancement of NMDA-evoked currents
High-performance liquid chromatography (HPLC) measurements of extracellular recording solutions revealed that contaminating levels of glycine and serine were both below the level of detectability (4 mM). Glycine concentrations were also below the level of detectability in concentrated solutions (100 ng/10 ml) of the neurotrophins. Hence, we FIG . 4. Effect of BDNF on NMDA-induced currents is dependent on estimate that the contamination contributed by the BDNF the extracellular concentration of glycine. In the absence of added glycine, solution only could have raised the nominal glycine concen-BDNF (10 ng/ml) substantially enhanced NMDA currents recorded in a tration by õ4 nM. This is considerably lower than the likely cultured hippocampal neuron. However, in the presence of 10 mM glycine, BDNF did not enhance this current. In contrast, the shorter form of dynorphin (6-17) ( Fig. 8C ) and met-enkephalin (not 1995). Nevertheless, to further determine if the effects of BDNF could be attributed to contamination of the BDNF shown) failed to enhance NMDA-activated currents recorded in low concentrations of glycine. with glycine, we investigated the effects of extracellular Mg 2/ on BDNF-versus glycine-induced enhancements of NMDA-activated currents. In cultured and isolated hippo-D I S C U S S I O N campal neurons, Mg 2/ enhances responses to glycine Our results demonstrate that neurotrophins can rapidly (Paoletti et al. 1995; Wang and MacDonald 1995) in part and reversibly enhance NMDA-evoked currents in striatal by increasing the affinity of the receptor for glycine. If and hippocampal neurons. This response was observed in BDNF were contaminated with glycine, we would anticipate cultured and isolated neurons using either perforated or that this divalent cation also would enhance the response whole cell patch techniques as well as in outside-out patches. to BDNF. However, responses to BDNF were depressed
The increase in the probability of NMDA channel opening substantially (Fig. 6, A and C) even though Mg 2/ consisassociated with applications of BDNF to outside-out patches tently enhanced responses to glycine (Fig. 6B ) (also Paoletti suggests that second messengers are not likely to be inet al. 1995; Wang and MacDonald 1995) .
volved. In addition, all of the neurotrophins enhanced NMDA receptor-mediated responses, suggesting that the ac-BDNF increases the open probability of NMDA channels tions of neurotrophins were not mediated through the selective activation of a given Trk receptor. Furthermore, NGF In outside-out patches taken from cultured hippocampal neurons and held at 060 mV, BDNF increased the open was effective even though TrkA receptors are not expressed in cultured hippocampal neurons (Ip et al. 1993) . The failure probability of NMDA channels (Fig. 7) . In control solutions (5 mM NMDA; 100 nM glycine), the probability of NMDA of the kinase inhibitors to block the enhancement also demonstrates that tyrosine kinases as well as serine-threonine channels being in the open state was 0.017 { 0.003 compared with 0.043 { 0.007 (n Å 5; P õ 0.05) in the presence protein kinases were unlikely to have been responsible for this response. A more likely explanation is that the neuro-of BDNF (10 ng/ml). In contrast, single-channel amplitude and open time were unaltered by BDNF (Fig. 7, C and D) . trophins act directly on the NMDA receptor itself. However, we could not demonstrate a shift in the affinity of the receptor Our results suggest that BDNF and other neurotrophins can interact directly with the glycine site of the NMDA for glycine by BDNF. Because both BDNF and glycine potentiate NMDA-evoked currents, reduce their desensitiza-receptor. Other peptides also may interact in a similar manner. For example, Brauneis et al. (1996) recently reported tion, and increase the probability of channel opening, we suggest that BDNF is capable of substituting for the coago-that the peptide dynorphin (dynorphin 1-13) caused a glycine-dependent enhancement of recombinant NMDA recep-nist glycine. On the other hand, our results demonstrate that the enhancement of NMDA-evoked currents by BDNF is tor-induced currents expressed in Xenopus oocytes. This enhancement changed to a depression when the solutions con-depressed by Mg 2/ even though this divalent cation increases the affinity for glycine and potentiates the response tained saturating concentrations of glycine. However, the shortened peptide (dynorphin 4-13), which lacks terminal to this amino acid. This suggests that BDNF is unlikely to act simply as a partial agonist at the glycine site. glycine residues, was without effect on NMDA currents, suggesting that these residues could substitute for free gly-Is the enhancement by BDNF simply due to contamination of the BDNF solution with glycine? Experiments investigat-cine. For this reason, we compared the effects of dynorphin (1-17) and dynorphin (6-17) with those of BDNF. Dynor-ing the effects of extracellular Mg 2/ on BDNF-versus glycine-induced enhancements of NMDA-evoked currents re-phin (1-17) caused a glycine-dependent enhancement of NMDA currents, and, in high concentrations of glycine, this vealed that this was not the case. As previously reported by Wang and MacDonald (1995) , extracellular Mg 2/ enhances peptide depressed NMDA currents (Fig. 8) . Another peptide somatostatin also caused a glycine-dependent enhancement the affinity of the NMDA receptor for glycine and increases FIG . 6. Mg 2/ depresses the enhancement of NMDA-evoked currents induced by BDNF. BDNF (A) or glycine (B) potentiated NMDA currents in cultured hippocampal neurons. Coapplications of NMDA and Mg 2/ also enhanced these currents. However, Mg 2/ consistently depressed the potentiation induced by BDNF alone while enhancing the response to glycine. Holding potential, /30 mV. Summary data are presented beside the example recordings (C We and others (Brauneis et al. 1996) have shown that several peptides including neurotrophins, somatostatin and dynorphin, can cause a glycine-dependent potentiation of NMDA-activated currents. In the case of dynorphin, the enhancement depends on the presence of several glycine residues in the N terminus of the peptide because the shortened form of dynorphin (4-13), which lacks these glycines, is ineffective (Brauneis et al. 1996) . It was suggested that the peptide containing these residues (Brauneis et al. 1996) may have substituted for free glycine at the NMDA receptor. We have confirmed this observation in that dynorphin (1-17)enhanced NMDA-induced currents in a glycine-dependent fashion, whereas a shortened form of dynorphin (6-17) was without effect. This suggests that neurotrophins dynorphin and somatostatin may have acted via a similar mechanism to potentiate NMDA currents. However, the dynorphin FIG . 7. BDNF increases the open probability of NMDA channels in an outside-out patch taken from a cultured hippocampal neuron. An example record showing the NMDA channel activity in an outside-out patch before, in the presence of, and after washout of BDNF ( A; 10 ng /ml ) is shown. In this example, NMDA evoked multiple openings, indicating the presence of more than one channel in the patch. Solid bar indicates the duration of the BDNF application. Holding potential was 060 mV, and NMDA ( 5 mM ) and glycine ( 100 nM ) were included in the extracellular solution. Portions of the record are displayed at an expanded time scale ( B ) . Probability of NMDA channels being in the open state was increased by BDNF 10 ng /ml ( control, 0.017 { 0.003; FIG . 8. Other peptides also cause a glycine-dependent enhancement of BDNF, 0.043 { 0.007, n Å 5; P õ 0.05 ) . Amplitude histograms in the NMDA currents. In an isolated CA1 pyramidal neuron, application of dyabsence and in the presence of BDNF are shown ( C ) . BDNF did not norphin (1-17) (5 mM) caused a voltage-independent potentiation of change the amplitude of single channel currents ( control, 2.4 { 0.8 NMDA-evoked currents (A). However, in the same cell, when glycine was pA; BDNF, 2.6 { 0.6 pA; n Å 5, P ú 0.05 ) . Open time histograms in increased to saturating concentration, the enhancement was replaced by a the absence and in the presence of BDNF ( 10 ng /ml; D ) . Open time depression (also voltage-independent; B). These results were confirmed in histograms were well fit with 2 exponentials. Both short and long open 5 cells. Similar results (D) were observed with applications of somatostatin times were unaffected by BDNF ( control t short Å 0.52 { 0.06 ms, (SST, 5 mM, n Å 5). In contrast, the shortened form of dynorphin (6-17) t long Å 4.9 { 0.32 ms, n Å 6; BDNF t short Å 0.47 { 0.08 ms, t long Å was unable to potentiate NMDA-evoked currents recorded in low concentra-4.4 { 0.037 ms, n Å 6 ) .
tions of glycine (n Å 5; C).
